Pragmatic trial of pharmacogenetic testing at the time of prescription for a selective serotonin reuptake inhibitor, tricyclic antidepressant or atypical antipsychotic. Does real time intervention improve patient outcomes?
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
130
Basic pharmacogenetic panel
Patient oriented outcome1- Clinical Improvement
Clinically significant improvement as noted by physician (Subjective and PHQ-9)
Time frame: 6 months
Patient oriented outcome2- Adverse effects
Number of patients with specific, common side effects (from medical chart)
Time frame: 6 months
Patient oriented outcome3- Time to Improvement
Days to clinical improvement (from medical chart)
Time frame: Up to 6 months
Patient oriented outcome5- Visits
Total number of visits to clinic with medication titration required (from medical chart)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.